Category: Uncategorized

GENEGUT Behind the Scenes: CarboHyde

Welcome to the next edition of our “GENEGUT: Behind the Scenes” series — where we spotlight the passionate teams driving innovation across the GENEGUT project. Today, we introduce CarboHyde, based in Budapest, Hungary.

GENEGUT: From Lab to Life – Modeling IBD in vitro: a tool to foster innovative therapeutics translation

Our improved 3D model plays a big role in the GENEGUT project as a testing platform to check if the new nano-based treatments we’re developing are safe and effective in IBD treatment.

GENEGUT Behind the Scenes: I3S – Institute of Science and Innovation in Health, University of Porto

Welcome to the next edition of our “GENEGUT: Behind the Scenes” series — where we spotlight the passionate teams driving innovation across the GENEGUT project. Today, we introduce i3S – Institute of Science and Innovation in Health, based in Porto, Portugal.

Voices of GENEGUT: Reflections for World IBD Day 2025

To mark World IBD Day 2025, the GENEGUT project is proud to share a special interview featuring voices from across the IBD community. This year’s campaign, “IBD Has No Borders: Breaking Taboos, Talking About It”, launched by EFCCA, GENEGUT’s project partner, shines a spotlight on the ongoing stigma and silence that many people living with IBD still face today.

GENEGUT: From Lab to Life – The Next Step in Drug Delivery: Smart Capsules

Our recent review explored the state of the art in smart capsule design, from power supplies and release mechanisms to localisation strategies and future materials. While hurdles remain, ongoing innovation is rapidly bringing this technology closer to real-world application.

Exploring Patient Perspectives on Diet and IBD: A Publication from UCC Researchers

While not part of the GENEGUT project itself, a recent publication by researchers from University College Cork (UCC) — a GENEGUT project coordinator — closely aligns with GENEGUT’s mission to explore the role of the gut in chronic disease and innovate therapeutic strategies.

GENEGUT Seminar Series: Designing solutions for overcoming barriers to gastrointestinal mRNA delivery | Dr. Ameya Kirtane

We are excited to announce the second online seminar in the GENEGUT series, this time featuring Dr. Ameya Kirtane from the University of Minnesota as our guest speaker. His talk, titled “Designing solutions for overcoming barriers to gastrointestinal mRNA delivery”, will take place on 5 June 2025 from 4–5 PM CET.

Horizon Europe EFCCA Academy: Diving into the future of IBD Therapies

Our GENEGUT partners from EFCCA have launched a new online training initiative: Horizon Europe EFCCA Academy: Diving into the future of IBD Therapies.

GENEGUT Synergies: Advancing Oral Site-Specific Delivery Through Academic–Industry Collaboration

The GENEGUT project exemplifies the strength of academic–industry collaboration, bringing together Lonza Capsules & Health Ingredients (Lonza) and the drug delivery group in the School of Pharmacy at University College Cork (UCC).

PostDoc position in GENEGUT

The GENEGUT consortium is currently looking for an exceptionally enthusiastic, creative, and driven Post-Doctoral Researcher with a passion for interdisciplinary science.